Proteomics in neurodegeneration--disease driven approaches

Area of Science:

• Proteomics
• Neuroscience
• Molecular Biology

Background:

• Proteins orchestrate biological processes, but their function is context-dependent.
• Gene sequence alone cannot predict protein function or disease involvement.
• Neurodegenerative diseases like Alzheimer's and Parkinson's involve complex protein dysregulation.

Purpose of the Study:

• To review proteomics technologies for analyzing protein expression in neurodegenerative diseases.
• To discuss the advantages and challenges of applying proteomics to brain tissue.
• To highlight the need for systems-level analysis of genes and proteins.

Main Methods:

• Review of current proteomics technologies.
• Analysis of protein expression in single cells, tissues, and whole organisms.
• Focus on brain tissue analysis for Alzheimer's and Parkinson's disease.

Main Results:

• Proteomics allows simultaneous investigation of thousands of proteins.
• Identification of cellular alterations linked to neurodegeneration.
• Potential for discovering novel diagnostic and therapeutic targets.

Conclusions:

• Proteomics offers powerful tools to understand neurodegenerative disease pathogenesis.
• Context-dependent protein analysis is essential for biological understanding.
• Further research in proteomics can advance diagnostics and therapeutics for Alzheimer's and Parkinson's.